$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Companies say they will submit shot for approval in US and EU within days
Airline aims to convince ministers to drop quarantine for passengers arriving in Britain
Lossmaking biotech aims to prove doubters wrong after patent probes and controversy over stock sales
‘Astounding’ switch into unloved industries breaks records
Eyeing path to pandemic’s end, investors chase travel, energy and financial stocks higher
Second set of positive results in a week boosts hope vaccines will be effective
Announcement is welcome antidote to warnings of ‘long winter’ as infections increase
Covid-19 jab may represent proof of concept for other treatments made by the group
Medical professionals argue GPs should lead distribution of vaccines when they are approved for use
Jab is third experimental inoculation to enter late-stage trials in country
Facilities with capacity to process 600,000 diagnostic checks a day set for Midlands and Scotland
Innovative backbone of country’s economy well-placed to reap benefits of vaccine breakthrough
Breakthrough in fight against Covid-19 caused ‘unprecedented’ rotation in stocks
Head of Operation Warp Speed warns thousands of lives at stake if project is interrupted
Government and citizens must discuss how to allocate anti-Covid remedies
The husband and wife team behind the German company are pioneers in a technology that could transform medicine
Kate Bingham praised for securing access to one of the world’s largest portfolios of coronavirus vaccines
Medical freezer suppliers spy an opportunity
Lockdowns, contact tracing and public adherence to tough rules credited for success
Reality check on rollout of treatment stems sell-off in Treasuries
Member of US president-elect’s Covid-19 task force says focus should shift to testing
NHS Providers warns hundreds of thousands of patients could be at risk
UK Edition
